Clinical Trial Detail

NCT ID NCT03334409
Title Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Indications

clear cell renal cell carcinoma

Therapies

Pazopanib

Age Groups: adult senior

No variant requirements are available.